Effect of Skip Lymphovascular Invasion on Hepatic Metastasis in Colorectal Carcinomas

Overview

Journal Int J Clin Oncol

Specialty Oncology

Date 2014 Dec 9

PMID 25483315

Citations 8

Authors

Yosuke Okamoto

Hiroyuki Mitomi

Kazuhito Ichikawa

Shigeki Tomita

Takahiro Fujimori

Yoshinori Igarashi

Affiliations

Soon will be listed here.

Abstract

Background: "Skip" lymphovascular invasion presenting as discontinuous foci of tumor cells within the colon wall is now excluded from consideration when determining T stage in the TNM classification. The purpose of this study was to assess the clinicopathological characteristics of colorectal cancer (CRC) patients with such skip lymphovascular invasion.

Methods: First, a retrospective questionnaire survey of the incidence of skip lymphovascular invasion was performed for a total of 1,868 patients with CRCs at ten institutions. Next, we comparatively assessed clinicopathological data for 896 CRC patients with or without skip lymphovascular invasion.

Results: The incidence of skip lymphovascular invasion was 1.1 % (20 out of 1,868). Most of the affected cases were rectal, pT2, and node negative, with moderately differentiated histology. Skip lymphovascular invasion was present in the muscularis propria and subserosa, with the tumors directly invading submucosa (pT1) or muscularis propria (pT2). Hepatic metastasis was greater in CRC with skip lymphovascular invasion (25 %) than in pT1/2 CRC (0 %; P < 0.001) or pT3 CRC without such invasion (13.8 %; P = 0.185).

Conclusions: Our study suggests that skip lymphovascular invasion is associated with hepatic metastasis in CRC cases. Thus, definition of a T category including such invasion would be useful for clinical practice.

Citing Articles

Early-stage sigmoid colon cancer resection followed by liver metastasis recurrence 1 year later and mesenteric recurrence more than 5 years later: a case report.

Mikuni Y, Tani M, Ichikawa N, Matsui H, Emoto S, Yoshida T Surg Case Rep. 2023; 9(1):151.

PMID: 37650976 PMC: 10471527. DOI: 10.1186/s40792-023-01731-7.

Low risk of local recurrence after a successful en bloc endoscopic submucosal dissection for noninvasive colorectal lesions with positive horizontal resection margins (R-ESD study).

Haasnoot K, Baldaque-Silva F, Koch A, Figueiredo Ferreira M, Santos-Antunes J, Dias E Endoscopy. 2022; 55(3):245-251.

PMID: 36228648 PMC: 9974332. DOI: 10.1055/a-1960-3552.

Tumor Size >5 cm and Harvested LNs <12 Are the Risk Factors for Recurrence in Stage I Colon and Rectal Cancer after Radical Resection.

Jung H, Ryoo S, Lim H, Kim M, Moon S, Park J Cancers (Basel). 2021; 13(21).

PMID: 34771458 PMC: 8582375. DOI: 10.3390/cancers13215294.

Early T Stage Is Associated With Poor Prognosis in Patients With Metastatic Liver Colorectal Cancer.

Wu L, Fu J, Chen Y, Wang L, Zheng S Front Oncol. 2020; 10:716.

PMID: 32626650 PMC: 7314979. DOI: 10.3389/fonc.2020.00716.

Preceding endoscopic submucosal dissection for T1 colorectal carcinoma does not affect the prognosis of patients who underwent additional surgery: a large multicenter propensity score-matched analysis.

Yamashita K, Oka S, Tanaka S, Nagata S, Hiraga Y, Kuwai T J Gastroenterol. 2019; 54(10):897-906.

PMID: 31104172 DOI: 10.1007/s00535-019-01590-w.

References

Tanaka S, Oka S, Chayama K . Colorectal endoscopic submucosal dissection: present status and future perspective, including its differentiation from endoscopic mucosal resection. J Gastroenterol. 2008; 43(9):641-51. DOI: 10.1007/s00535-008-2223-4. View

Minsky B, Mies C, Rich T, Recht A . Lymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer. Int J Radiat Oncol Biol Phys. 1989; 17(2):311-8. DOI: 10.1016/0360-3016(89)90445-8. View

Roxburgh C, McMillan D, Richards C, Atwan M, Anderson J, Harvey T . The clinical utility of the combination of T stage and venous invasion to predict survival in patients undergoing surgery for colorectal cancer. Ann Surg. 2013; 259(6):1156-65. DOI: 10.1097/SLA.0000000000000229. View

Harris E, Lewin D, Wang H, Lauwers G, Srivastava A, Shyr Y . Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am J Surg Pathol. 2008; 32(12):1816-21. PMC: 2605104. DOI: 10.1097/PAS.0b013e3181816083. View

Compton C, Fielding L, Burgart L, Conley B, Cooper H, Hamilton S . Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000; 124(7):979-94. DOI: 10.5858/2000-124-0979-PFICC. View

Jessup J, Stewart A, Greene F, Minsky B . Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005; 294(21):2703-11. DOI: 10.1001/jama.294.21.2703. View

Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y . Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2011; 17(1):1-29. DOI: 10.1007/s10147-011-0315-2. View

Gertler R, Rosenberg R, Schuster T, Friess H . Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy. Eur J Cancer. 2009; 45(17):2992-9. DOI: 10.1016/j.ejca.2009.07.008. View

Kitajima K, Fujimori T, Fujii S, Takeda J, Ohkura Y, Kawamata H . Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol. 2004; 39(6):534-43. DOI: 10.1007/s00535-004-1339-4. View

10.

Center M, Jemal A, Smith R, Ward E . Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009; 59(6):366-78. DOI: 10.3322/caac.20038. View

11.

Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N . Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol. 2009; 27(31):5131-7. PMC: 2773472. DOI: 10.1200/JCO.2009.22.4949. View

12.

Washington M, Berlin J, Branton P, Burgart L, Carter D, Fitzgibbons P . Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med. 2009; 133(10):1539-51. PMC: 2901838. DOI: 10.5858/133.10.1539. View

13.

Ueno H, Shirouzu K, Eishi Y, Yamada K, Kusumi T, Kushima R . Characterization of perineural invasion as a component of colorectal cancer staging. Am J Surg Pathol. 2013; 37(10):1542-9. DOI: 10.1097/PAS.0b013e318297ef6e. View

14.

Mitomi H, Mori A, Kanazawa H, Nishiyama Y, Ihara A, Otani Y . Venous invasion and down-regulation of p21(WAF1/CIP1) are associated with metastasis in colorectal carcinomas. Hepatogastroenterology. 2005; 52(65):1421-6. View

15.

Shirouzu K, Isomoto H, Kakegawa T, Morimatsu M . A prospective clinicopathologic study of venous invasion in colorectal cancer. Am J Surg. 1991; 162(3):216-22. DOI: 10.1016/0002-9610(91)90073-m. View

16.

Lim S, Yu C, Jang S, Kim T, Kim J, Kim J . Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum. 2010; 53(4):377-84. DOI: 10.1007/DCR.0b013e3181cf8ae5. View

17.

Ueno H, Mochizuki H, Hashiguchi Y, Ishiguro M, Miyoshi M, Kajiwara Y . Extramural cancer deposits without nodal structure in colorectal cancer: optimal categorization for prognostic staging. Am J Clin Pathol. 2007; 127(2):287-94. DOI: 10.1309/903UT10VQ3LC7B8L. View

18.

Gray R, Barnwell J, McConkey C, Hills R, Williams N, Kerr D . Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007; 370(9604):2020-9. DOI: 10.1016/S0140-6736(07)61866-2. View

19.

Qiu H, Chen G, Keshari R, Luo H, Fang W, Qiu M . The extramural metastasis might be categorized in lymph node staging for colorectal cancer. BMC Cancer. 2011; 11(1):414. PMC: 3190391. DOI: 10.1186/1471-2407-11-414. View